Sep 27, 2018
Regulus to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 26, 2018
Regulus Provides Pipeline Updates
Aug 09, 2018
Regulus Reports Second Quarter 2018 Financial Results and Recent Updates
Jul 05, 2018
Regulus Announces Strategic Update and Corporate Restructuring
Jun 01, 2018
Alport Syndrome Pipeline Analysis 2018: 5 Drugs Currently in Different Phases of Development
May 10, 2018
Regulus Reports First Quarter 2018 Financial Results and Pipeline Progress
May 03, 2018
Regulus to Provide First Quarter 2018 Financial Results on May 10, 2018
May 01, 2018
Regulus Initiates Multiple Ascending Dose Study in Healthy Volunteers of RGLS4326 for the Treatment of ADPKD
Apr 17, 2018
Kathryn J. Collier Joins Regulus Board of Directors
Mar 20, 2018
Quotidian Technical Highlights on Selected Biotech Stocks -- Portola Pharma, Protalix BioTherapeutics, Radius Health, and Regulus Therapeutics
Mar 07, 2018
Regulus Reports Fourth Quarter and Year-end 2017 Financial Results and Pipeline Update
Mar 05, 2018
Regulus to Present at the Cowen and Company 38th Annual Health Care Conference
Feb 28, 2018
Regulus to Provide Fourth Quarter and Year-end 2017 Financial Results on March 7, 2018
Feb 22, 2018
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
Feb 13, 2018
This Morning's Technical Outlook on Biotech Stocks -- Portola Pharma, Protalix BioTherapeutics, Radius Health, and Regulus Therapeutics
Feb 08, 2018
Regulus to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference
Dec 26, 2017
Technical Perspectives on Argos Therapeutics, Omeros, Regulus Therapeutics, and Rhythm Pharma
Dec 19, 2017
Regulus Announces First-in-Human Dosing for Phase I Study of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
Nov 07, 2017
Regulus Reports Third Quarter 2017 Financial Results and Recent Events
Oct 10, 2017
Global MicroRNA Research Tools, Diagnostics and Therapeutics Markets 2017 - Key Players are Thermo Fisher Scientific, Agilent Technologies, Qiagen, Illumina, F. Hoffmann-La Roche & Bio-Rad